| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2006-08-13 09:23:04 UTC |
|---|
| Update Date | 2022-09-22 17:43:51 UTC |
|---|
| HMDB ID | HMDB0004030 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 21-Deoxycortisol |
|---|
| Description | Plasma 21-deoxycortisol (21DF) is an excellent marker of 21-hydroxylase deficiency. Currently, it is the only marker able to detect heterozygous carriers with 21-hydroxylase deficiency after Adrenocorticotropic Hormone (ACTH) stimulation. The syndrome of congenital adrenal hyperplasia (CAH) comprises the spectrum of autosomal recessive enzymatic disorders that impair cortisol biosynthesis. The hormonal pattern and clinical manifestations result from hyperstimulation of the adrenal cortex by excessive production of ACTH, untied from the negative feedback exerted by reduced cortisol levels, and the ultimate accumulation of F precursors and androgens. These abnormalities predispose the female newborn to ambiguous genitalia (female pseudohermaphroditism) and precocious puberty that may occur in both sexes. CAH due to 21-hydroxylase deficiency (21OHD) comprises nearly 90% of all cases, with an estimated worldwide incidence of 1 in 14,000 live births. Because 21-deoxycortisol (21DF) is an 11b-hydroxylase (11bOH) derivative of 17-hydroxyprogesterone (17OHP), its serum levels are parallel and proportionally elevated in patients with 21OHD but decreased or undetectable in those with 11b-hydroxylase deficiency (11bOHD), another genetic disorder. Due to the marked buildup of 17OHP in 21OHD, this precursor steroid can proceed directly to 11-hydroxylation, producing distinct elevations of 21DF (PMID: 16551734 , 10731638 ). |
|---|
| Structure | [H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)C[C@@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C InChI=1S/C21H30O4/c1-12(22)21(25)9-7-16-15-5-4-13-10-14(23)6-8-19(13,2)18(15)17(24)11-20(16,21)3/h10,15-18,24-25H,4-9,11H2,1-3H3/t15-,16-,17+,18+,19-,20-,21-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 11b,17-Dihydroxy-pregn-4-ene-3,20-dione | HMDB | | 11b,17-Dihydroxy-progesterone | HMDB | | 11b,17a-Dihydroxypregn-4-ene-3,20-dione | HMDB | | 11b,17a-Dihydroxyprogesterone | HMDB | | 21-Dehydrohydrocortisone | HMDB | | 21-Deoxyhydrocortisone | HMDB | | 21-Desoxycortisol | HMDB | | 4-Pregnene-11beta,17alpha-diol-3,20-dione | HMDB | | Pregn-4-ene-11b,17a-diol-3,20-dione | HMDB |
|
|---|
| Chemical Formula | C21H30O4 |
|---|
| Average Molecular Weight | 346.4605 |
|---|
| Monoisotopic Molecular Weight | 346.214409448 |
|---|
| IUPAC Name | (1S,2R,10S,11S,14R,15S,17R)-14-acetyl-14,17-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one |
|---|
| Traditional Name | 21-deoxycortisol |
|---|
| CAS Registry Number | 641-77-0 |
|---|
| SMILES | [H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)C[C@@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C |
|---|
| InChI Identifier | InChI=1S/C21H30O4/c1-12(22)21(25)9-7-16-15-5-4-13-10-14(23)6-8-19(13,2)18(15)17(24)11-20(16,21)3/h10,15-18,24-25H,4-9,11H2,1-3H3/t15-,16-,17+,18+,19-,20-,21-/m0/s1 |
|---|
| InChI Key | LCZBQMKVFQNSJR-CZUPSRJTSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Pregnane steroids |
|---|
| Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Progestogin-skeleton
- 20-oxosteroid
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- Hydroxysteroid
- Oxosteroid
- 11-alpha-hydroxysteroid
- 11-hydroxysteroid
- 17-hydroxysteroid
- Delta-4-steroid
- Cyclohexenone
- Tertiary alcohol
- Alpha-hydroxy ketone
- Cyclic alcohol
- Secondary alcohol
- Ketone
- Cyclic ketone
- Organic oxide
- Organooxygen compound
- Alcohol
- Organic oxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.47 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.7283 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.29 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2530.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 217.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 183.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 169.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 176.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 550.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 561.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 82.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1031.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 440.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1381.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 333.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 401.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 290.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 299.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 17.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 21-Deoxycortisol,1TMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3169.1 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,1TMS,isomer #2 | CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 3086.7 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,1TMS,isomer #3 | CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3026.5 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,1TMS,isomer #4 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3061.3 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,2TMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 3099.3 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,2TMS,isomer #2 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3078.9 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,2TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3137.6 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,2TMS,isomer #4 | CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 2946.4 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,2TMS,isomer #5 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 2992.5 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,2TMS,isomer #6 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 2975.2 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,3TMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 2965.9 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,3TMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 2992.6 | Standard non polar | 33892256 | | 21-Deoxycortisol,3TMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 3274.5 | Standard polar | 33892256 | | 21-Deoxycortisol,3TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 3048.7 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,3TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 2974.9 | Standard non polar | 33892256 | | 21-Deoxycortisol,3TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 3339.4 | Standard polar | 33892256 | | 21-Deoxycortisol,3TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3015.7 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,3TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3072.0 | Standard non polar | 33892256 | | 21-Deoxycortisol,3TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3385.0 | Standard polar | 33892256 | | 21-Deoxycortisol,3TMS,isomer #4 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 2880.7 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,3TMS,isomer #4 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 2957.8 | Standard non polar | 33892256 | | 21-Deoxycortisol,3TMS,isomer #4 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 3427.4 | Standard polar | 33892256 | | 21-Deoxycortisol,4TMS,isomer #1 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 2943.5 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,4TMS,isomer #1 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 3014.3 | Standard non polar | 33892256 | | 21-Deoxycortisol,4TMS,isomer #1 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C)C[C@@]21C | 3280.8 | Standard polar | 33892256 | | 21-Deoxycortisol,1TBDMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3406.1 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,1TBDMS,isomer #2 | CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3329.1 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,1TBDMS,isomer #3 | CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3280.4 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,1TBDMS,isomer #4 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3315.2 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,2TBDMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3584.6 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,2TBDMS,isomer #2 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3561.1 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,2TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3613.7 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,2TBDMS,isomer #4 | CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3394.9 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,2TBDMS,isomer #5 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3471.4 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,2TBDMS,isomer #6 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3457.6 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,3TBDMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3634.8 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,3TBDMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3628.6 | Standard non polar | 33892256 | | 21-Deoxycortisol,3TBDMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3520.0 | Standard polar | 33892256 | | 21-Deoxycortisol,3TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3735.7 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,3TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3653.8 | Standard non polar | 33892256 | | 21-Deoxycortisol,3TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3581.9 | Standard polar | 33892256 | | 21-Deoxycortisol,3TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3714.7 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,3TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3663.9 | Standard non polar | 33892256 | | 21-Deoxycortisol,3TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O)C[C@@]21C | 3615.9 | Standard polar | 33892256 | | 21-Deoxycortisol,3TBDMS,isomer #4 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3534.0 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,3TBDMS,isomer #4 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3572.8 | Standard non polar | 33892256 | | 21-Deoxycortisol,3TBDMS,isomer #4 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3671.5 | Standard polar | 33892256 | | 21-Deoxycortisol,4TBDMS,isomer #1 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3753.5 | Semi standard non polar | 33892256 | | 21-Deoxycortisol,4TBDMS,isomer #1 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3749.7 | Standard non polar | 33892256 | | 21-Deoxycortisol,4TBDMS,isomer #1 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3[C@H](O[Si](C)(C)C(C)(C)C)C[C@@]21C | 3539.6 | Standard polar | 33892256 |
|
|---|
| Disease References | | 21-Hydroxylase deficiency |
|---|
- Tonetto-Fernandes V, Lemos-Marini SH, Kuperman H, Ribeiro-Neto LM, Verreschi IT, Kater CE: Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2006 Jun;91(6):2179-84. Epub 2006 Mar 21. [PubMed:16551734 ]
| | Congenital Adrenal Hyperplasia, due to 21-Hydroxylase-Deficiency |
|---|
- Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J: Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab. 2007 Jul;92(7):2581-9. Epub 2007 Apr 24. [PubMed:17456574 ]
| | Preterm birth |
|---|
- Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J: Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab. 2007 Jul;92(7):2581-9. Epub 2007 Apr 24. [PubMed:17456574 ]
| | Testicular adrenal rest tumors |
|---|
- Claahsen-van der Grinten HL, Otten BJ, Sweep FC, Span PN, Ross HA, Meuleman EJ, Hermus AR: Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue. J Clin Endocrinol Metab. 2007 Sep;92(9):3674-80. Epub 2007 Jun 26. [PubMed:17595257 ]
| | 11-beta-Hydroxylase deficiency |
|---|
- Tonetto-Fernandes V, Lemos-Marini SH, Kuperman H, Ribeiro-Neto LM, Verreschi IT, Kater CE: Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2006 Jun;91(6):2179-84. Epub 2006 Mar 21. [PubMed:16551734 ]
|
|
|---|
| General References | - Solish SB, Goldsmith MA, Voutilainen R, Miller WL: Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1989 Dec;69(6):1148-52. [PubMed:2555382 ]
- Gueux B, Fiet J, Couillin P, Raux-Demay MC, Mornet E, Galons H, Villette JM, Boue J, Dreux C: Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia by simultaneous radioimmunoassay of 21-deoxycortisol and 17-hydroxyprogesterone in amniotic fluid. J Clin Endocrinol Metab. 1988 Mar;66(3):534-7. [PubMed:3258316 ]
- Finkelstein M, Litvin Y, Mizrachi Y, Neiman G, Rosler A: Apparent double defect in C11 beta and C21-steroid hydroxylation in congenital adrenal hyperplasia. J Steroid Biochem. 1983 Jul;19(1B):675-81. [PubMed:6310249 ]
- Penny R, Vecsei P: Congenital adrenal hyperplasia due to combined 21- and 11 beta-hydroxylase deficiency. J Endocrinol Invest. 1989 Nov;12(10):723-8. [PubMed:2614011 ]
- Fiet J, Gueux B, Raux-Demay MC, Kuttenn F, Vexiau P, Gourmelen M, Couillin P, Mornet E, Villette JM, Brerault JL, et al.: [21-deoxycortisol. A new marker of virilizing adrenal hyperplasia caused by 21-hydroxylase deficiency]. Presse Med. 1989 Dec 2;18(40):1965-9. [PubMed:2531882 ]
- Tonetto-Fernandes V, Lemos-Marini SH, Kuperman H, Ribeiro-Neto LM, Verreschi IT, Kater CE: Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2006 Jun;91(6):2179-84. Epub 2006 Mar 21. [PubMed:16551734 ]
- Fiet J, Boudi A, Giton F, Villette JM, Boudou P, Soliman H, Morineau G, Galons H: Plasma 21-deoxycortisol: comparison of a time-resolved fluoroimmunoassay using a biotinylated tracer with a radioimmunossay using (125)iodine. J Steroid Biochem Mol Biol. 2000 Jan-Feb;72(1-2):55-60. [PubMed:10731638 ]
|
|---|